funder-graph

FundersILAmerican Society for Transplantation & Cellular Therapy › 2022

Grants paid by American Society for Transplantation & Cellular Therapy, tax year 2022

EIN 52-1850793 · Chicago, IL · Form 990, Schedule I · NTEE H20Z

In tax year 2022, American Society for Transplantation & Cellular Therapy (EIN 52-1850793) reported 6 grants paid totaling $330,000. Dataset version 2026.09.0, built 2026-09-03.

20192020202220232024

Every grant, 2022

Grants reported by American Society for Transplantation & Cellular Therapy for tax year 2022
Tax yearRecipientMatchAmountTypePurposeSource filing
2022Fred Hutchinson Cancer Research Center N Seattle, WAA$100,000paidNEW INVESTIGATOR AWARDS202303199349324935
2022Georgetown University Washington, DCA$50,000paidNEW INVESTIGATOR AWARDS202303199349324935
2022Trustees of the University of Pennsylvania Philadelphia, PAA$50,000paidNEW INVESTIGATOR AWARDS202303199349324935
2022St Jude Children's Research Hospital Memphis, TNA$50,000paidNEW INVESTIGATOR AWARDS202303199349324935
2022University of Texas Md Anderson Cancer Center Houston, TXA$50,000paidNEW INVESTIGATOR AWARDS202303199349324935
2022Dana-Farber Cancer Institute Boston, MAA$30,000paidNEW INVESTIGATOR AWARDS202303199349324935

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.